Medicine and Health

CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics

L. Hao, R. T. Zhao, et al.

This research introduces a groundbreaking method for detecting and differentiating disease states using chemically stabilized nucleic acids multiplexed with synthetic biomarkers. Conducted by renowned researchers including Liangliang Hao and Sangeeta N. Bhatia, this innovative approach utilizes urine analysis through CRISPR-Cas detection mechanisms, paving the way for a convenient point-of-care diagnostic tool.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

CRISPR-Cas Systems: A Promising Tool for Viral Disease Detection and Therapy

M.s., M.k., et al.

Engineering and Technology

Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges

R. P. Singh, A. Natarajan, et al.

Medicine and Health

The efficacy and adverse events of conventional and second-generation androgen receptor inhibitors for castration-resistant prostate cancer: A network meta-analysis

X. Zhang, G. Zhang, et al.

Medicine and Health

Fully implantable and battery-free wireless optoelectronic system for modulable cancer therapy and real-time monitoring

K. Kim, I. S. Min, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny